Outsourcing in Clinical Trials UK & Ireland 2023

Teckro is exhibiting and presenting during the OCT UK & Ireland in London. 

Events Page Form on Website

Attending: Outsourcing in Clinical Trials UK & Ireland 2023 Teckro Attended: SCRS West Site Solutions Summit 2023 🤝

We are exhibiting and presenting at Outsourcing in Clinical Trials (OCT) UK & Ireland. During the conference, our experts will be available to answer your questions and demo Teckro.

Brendan’s extensive experience as a senior clinical investigator fosters credible peer-to-peer conversations with prospective Teckro customers.

Brendan is a medical graduate of University College Cork (UCC) and a doctoral graduate in Biochemistry of Oxford University. He brings more than 40 years of experience in academic clinical practice as a physician in endocrinology, diabetes and clinical pharmacology.

Brendan is also a non-executive director of a number of biopharma development and services companies. He chairs the board of the leading Irish research charity, Fighting Blindness, and is a member of the board of Breakthrough Cancer Research. He was a member of the Board of Directors of the Irish Medicines Board (now the Health Products Regulatory Authority), chairing its statutory Advisory Committee for Human Medicines. In the past, he was also a member of the European Medicines Agency Committee for Orphan Medicinal Products (COMP) and of the European Medicines Agency (EMA) Scientific Advisory Committee on diabetes and metabolism.

Brendan is an Honorary Clinical Professor at UCC and an Adjunct Professor at University College Dublin in the respective medical faculties. He was Director of the European Collaborative Centre for Clinical Trials in Rare Diseases at UCC. With more than 150 scientific papers published in his career, Brendan also authored the opinion-leading book Re-Engineering Clinical Trials. He has directed a number of very large outcomes trials in metabolic/cardiovascular disease and chairs the independent data and safety monitoring boards for a number of large clinical development programs.

Brendan co-founded Firecrest Clinical, and when it was acquired by ICON served as Chief Medical Officer and Executive Vice President.

Chief Medical Officer

Dr. Brendan Buckley

Teckro will present the following speaking session at 10:30 a.m. on September 6:

The transition from a manual, paper-based approach to a digital first approach in clinical trials opens new opportunities for sponsors to achieve enhanced oversight on study progress, quality, and patient safety. This session will address how data insights generated from digital first clinical trials:

Identify areas for corrective action sooner

Generate learning capital for other trials

Read

Listen

Watch

Outsourcing in Clinical Trials UK & Ireland

September 5, 2023 | September 6

Hilton Park Lane, London

Description

Speakers

Rethinking Sponsor Oversight in a Digital First World

Dr. Brendan Buckley

Chief Medical Officer

Locations